Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Evogene to set up US R&D facility

The Israeli biotechnology company, Evogene (Rehovot), has agreed to establish a US research and development facility on the campus of the Donald Danforth Plant Science Center in St Louis, Missouri. The establishment of the facility is seen as a key component of the company's $10 million investment in the development of genetically modified insect-resistant crop traits. The 6,000 sq ft (557 m2) facility will feature state-of-the-art laboratories and insect rearing rooms and is expected to be fully operational by the end of the year, the company points out. It will support Evogene's insect control activities, initially focusing on corn rootworms (Diabrotica spp) and soybean aphids. The facility will incorporate field-specific modifications of the company's existing gene testing and validation infrastructure and new capabilities for targeting these and other high-impact pests, Evogene notes.



What to read next




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts